Quick Facts
FONT-SIZE Plus   Neg
Share SHARE

PetMed Express Q3 Profit Beats Estimates

RELATED NEWS
Trade PETS now with 

PetMed Express Inc. (PETS: Quote) posted third-quarter net income of $4.6 million, or $0.23 per share, compared to $3.9 million, or $0.19 per share in the comparable quarter last year. On average, seven analysts polled by Thomson Reuters expected the company to report profit of $0.18 per share. Analysts' estimates typically exclude special items.

Net sales for the latest third quarter quarter were $49.61 million, compared with $50.52 million in the year-ago quarter, while five analysts had a consensus revenue estimate of $49.97 million for the quarter.

Click here to receive FREE breaking news email alerts for PetMed Express Inc. and others in your portfolio

by RTT Staff Writer

For comments and feedback: editorial@rttnews.com

Business News

Quick Facts

Editors Pick
Shares of OvaScience Inc. (OVAS) have had a strong run in 2014, rising over 370 percent year-to-date. And that's indeed a very impressive return delivered by the fertility treatment company, which suffered a setback last year when it had to suspend a U.S. trial of its flagship fertility treatment due to regulatory concerns raised by the FDA. Nike Inc., the world's largest athletic shoes and apparel maker, said Thursday after the markets closed that its second quarter profit rose 23% from last year, helped by higher revenue and improved gross margin. The company's quarterly earnings per share also came in above analysts' expectations as did its quarterly revenue. Citing extreme fluctuation of the ruble, Apple Inc. (AAPL) has reportedly discontinued its online sales of products in Russia. Despite efforts of the Russian central bank, the ruble has been spiraling downward, with oil prices plunging to historic levels. The ruble shed around 19 percent on Wednesday....
comments powered by Disqus
FREE Newsletters, Analysis & Alerts

 

Stay informed with our FREE daily Newsletters and real-time breaking News Alerts. Sign up to receive the latest information on business news, health, technology, biotech, market analysis, currency trading and more.